{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:38:32Z","timestamp":1787495912827,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T00:00:00Z","timestamp":1423785600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s00464-015-4103-3","type":"journal-article","created":{"date-parts":[[2015,2,12]],"date-time":"2015-02-12T16:06:11Z","timestamp":1423757171000},"page":"3528-3534","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Reflux control is important in the management of Barrett\u2019s Esophagus: results from a retrospective 1,830 patient cohort"],"prefix":"10.1007","volume":"29","author":[{"given":"Craig S.","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Lapin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay L.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Linn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woody","family":"Denham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Haggerty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Talamonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Howington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joann","family":"Carbray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Ujiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,13]]},"reference":[{"key":"4103_CR1","first-page":"e449","volume":"17","author":"DM Sobieraj","year":"2011","unstructured":"Sobieraj DM, Coleman SM, Coleman CI (2011) US prevalence of upper gastrointestinal symptoms: a systematic literature review. Am J Manag Care 17:e449\u2013e458","journal-title":"Am J Manag Care"},{"key":"4103_CR2","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/ajg.2012.299","volume":"107","author":"G Balasubramanian","year":"2012","unstructured":"Balasubramanian G, Singh M, Gupta N, Gaddam S, Giacchino M, Wani SB, Moloney B, Higbee AD, Rastogi A, Bansal A, Sharma P (2012) Prevalence and predictors of columnar lined esophagus in gastroesophageal reflux disease (GERD) patients undergoing upper endoscopy. Am J Gastroenterol 107:1655\u20131661","journal-title":"Am J Gastroenterol"},{"key":"4103_CR3","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1572-0241.2004.04094.x","volume":"99","author":"EI Sihvo","year":"2004","unstructured":"Sihvo EI, Luostarinen ME, Salo JA (2004) Fate of patients with adenocarcinoma of the esophagus and the esophagogastric junction: a population-based analysis. Am J Gastroenterol 99:419\u2013424","journal-title":"Am J Gastroenterol"},{"key":"4103_CR4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ijc.11029","volume":"105","author":"AP Polednak","year":"2003","unstructured":"Polednak AP (2003) Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas. Int J Cancer J Int Du Cancer 105:98\u2013100","journal-title":"Int J Cancer J Int Du Cancer"},{"key":"4103_CR5","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1111\/j.1572-0241.2008.02191.x","volume":"103","author":"C Lepage","year":"2008","unstructured":"Lepage C, Rachet B, Jooste V, Faivre J, Coleman MP (2008) Continuing rapid increase in esophageal adenocarcinoma in England and Wales. Am J Gastroenterol 103:2694\u20132699","journal-title":"Am J Gastroenterol"},{"key":"4103_CR6","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2","volume":"83","author":"SS Devesa","year":"1998","unstructured":"Devesa SS, Blot WJ, Fraumeni JF Jr (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83:2049\u20132053","journal-title":"Cancer"},{"key":"4103_CR7","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.4065\/83.10.1087","volume":"83","author":"SJ Crane","year":"2008","unstructured":"Crane SJ, Locke GR 3rd, Harmsen WS, Zinsmeister AR, Romero Y, Talley NJ (2008) Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study. Mayo Clin Proc Mayo Clin 83:1087\u20131094","journal-title":"Mayo Clin Proc Mayo Clin"},{"key":"4103_CR8","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1572-0241.2005.41300.x","volume":"100","author":"GS Dulai","year":"2005","unstructured":"Dulai GS, Shekelle PG, Jensen DM, Spiegel BM, Chen J, Oh D, Kahn KL (2005) Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett\u2019s cohort. Am J Gastroenterol 100:775\u2013783","journal-title":"Am J Gastroenterol"},{"key":"4103_CR9","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/jnci\/djr203","volume":"103","author":"S Bhat","year":"2011","unstructured":"Bhat S, Coleman HG, Yousef F, Johnston BT, McManus DT, Gavin AT, Murray LJ (2011) Risk of malignant progression in Barrett\u2019s esophagus patients: results from a large population-based study. J Natl Cancer Inst 103:1049\u20131057","journal-title":"J Natl Cancer Inst"},{"key":"4103_CR10","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1158\/1055-9965.EPI-11-0547","volume":"20","author":"CY Kong","year":"2011","unstructured":"Kong CY, Nattinger KJ, Hayeck TJ, Omer ZB, Wang YC, Spechler SJ, McMahon PM, Gazelle GS, Hur C (2011) The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 20:2450\u20132456","journal-title":"Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol"},{"key":"4103_CR11","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/cncr.27834","volume":"119","author":"C Hur","year":"2013","unstructured":"Hur C, Miller M, Kong CY, Dowling EC, Nattinger KJ, Dunn M, Feuer EJ (2013) Trends in esophageal adenocarcinoma incidence and mortality. Cancer 119:1149\u20131158","journal-title":"Cancer"},{"key":"4103_CR12","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1111\/j.1572-0241.2002.05902.x","volume":"97","author":"B Avidan","year":"2002","unstructured":"Avidan B, Sonnenberg A, Schnell TG, Chejfec G, Metz A, Sontag SJ (2002) Hiatal hernia size, Barrett\u2019s length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Am J Gastroenterol 97:1930\u20131936","journal-title":"Am J Gastroenterol"},{"key":"4103_CR13","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1053\/gast.1997.v112.pm9178669","volume":"112","author":"N Chiba","year":"1997","unstructured":"Chiba N, De Gara CJ, Wilkinson JM, Hunt RH (1997) Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 112:1798\u20131810","journal-title":"Gastroenterology"},{"key":"4103_CR14","first-page":"1452","volume":"4","author":"IM Gralnek","year":"2006","unstructured":"Gralnek IM, Dulai GS, Fennerty MB, Spiegel BM (2006) Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 4:1452\u20131458","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"4103_CR15","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1001\/jama.2011.626","volume":"305","author":"JP Galmiche","year":"2011","unstructured":"Galmiche JP, Hatlebakk J, Attwood S, Ell C, Fiocca R, Eklund S, Langstrom G, Lind T, Lundell L, Collaborators LT (2011) Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA J Am Med Assoc 305:1969\u20131977","journal-title":"JAMA J Am Med Assoc"},{"key":"4103_CR16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.canep.2012.03.001","volume":"36","author":"JH Lubin","year":"2012","unstructured":"Lubin JH, Cook MB, Pandeya N, Vaughan TL, Abnet CC, Giffen C, Webb PM, Murray LJ, Casson AG, Risch HA, Ye W, Kamangar F, Bernstein L, Sharp L, Nyren O, Gammon MD, Corley DA, Wu AH, Brown LM, Chow WH, Ward MH, Freedman ND, Whiteman DC (2012) The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett\u2019s Esophagus and Esophageal Adenocarcinoma Consortium. Cancer Epidemiol 36:306\u2013316","journal-title":"Cancer Epidemiol"},{"key":"4103_CR17","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/ajg.2011.153","volume":"106","author":"M Sikkema","year":"2011","unstructured":"Sikkema M, Looman CW, Steyerberg EW, Kerkhof M, Kastelein F, van Dekken H, van Vuuren AJ, Bode WA, van der Valk H, Ouwendijk RJ, Giard R, Lesterhuis W, Heinhuis R, Klinkenberg EC, Meijer GA, ter Borg F, Arends JW, Kolkman JJ, van Baarlen J, de Vries RA, Mulder AH, van Tilburg AJ, Offerhaus GJ, ten Kate FJ, Kusters JG, Kuipers EJ, Siersema PD (2011) Predictors for neoplastic progression in patients with Barrett\u2019s Esophagus: a prospective cohort study. Am J Gastroenterol 106:1231\u20131238","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"4103_CR18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/ijc.28016","volume":"133","author":"TI Ibiebele","year":"2013","unstructured":"Ibiebele TI, Celia Hughes M, Nagle CM, Bain CJ, Whiteman DC, Webb PM (2013) Dietary antioxidants and risk of Barrett\u2019s esophagus and adenocarcinoma of the esophagus in an Australian population. Int J Cancer J Int Du Cancer\u00a0133(1):214\u2013224","journal-title":"Int J Cancer J Int Du Cancer"},{"key":"4103_CR19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/gut.2008.163360","volume":"58","author":"DA Corley","year":"2009","unstructured":"Corley DA, Kubo A, Levin TR, Block G, Habel L, Rumore G, Quesenberry C, Buffler P (2009) Race, ethnicity, sex and temporal differences in Barrett\u2019s oesophagus diagnosis: a large community-based study, 1994\u20132006. Gut 58:182\u2013188","journal-title":"Gut"},{"key":"4103_CR20","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jama.2014.2511","volume":"311","author":"KN Phoa","year":"2014","unstructured":"Phoa KN, van Vilsteren FG, Weusten BL, Bisschops R, Schoon EJ, Ragunath K, Fullarton G, Di Pietro M, Ravi N, Visser M, Offerhaus GJ, Seldenrijk CA, Meijer SL, ten Kate FJ, Tijssen JG, Bergman JJ (2014) Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA J Am Med Assoc 311:1209\u20131217","journal-title":"JAMA J Am Med Assoc"},{"key":"4103_CR21","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/hupa.2001.23510","volume":"32","author":"E Montgomery","year":"2001","unstructured":"Montgomery E, Bronner MP, Goldblum JR, Greenson JK, Haber MM, Hart J, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Toledano AY, Shyr Y, Washington K (2001) Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 32:368\u2013378","journal-title":"Hum Pathol"},{"key":"4103_CR22","first-page":"382","volume":"11","author":"F Kastelein","year":"2013","unstructured":"Kastelein F, Spaander MC, Steyerberg EW, Biermann K, Valkhoff VE, Kuipers EJ, Bruno MJ (2013) Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett\u2019s Esophagus. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 11:382\u2013388","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"4103_CR23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1159\/000331513","volume":"29","author":"F Kastelein","year":"2011","unstructured":"Kastelein F, Spaander MC, Biermann K, Vucelic B, Kuipers EJ, Bruno MJ (2011) Role of acid suppression in the development and progression of dysplasia in patients with Barrett\u2019s esophagus. Dig Dis 29:499\u2013506","journal-title":"Dig Dis"},{"key":"4103_CR24","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/j.1572-0241.2004.30228.x","volume":"99","author":"HB El-Serag","year":"2004","unstructured":"El-Serag HB, Aguirre TV, Davis S, Kuebeler M, Bhattacharyya A, Sampliner RE (2004) Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett\u2019s esophagus. Am J Gastroenterol 99:1877\u20131883","journal-title":"Am J Gastroenterol"},{"key":"4103_CR25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.5694\/j.1326-5377.2004.tb05991.x","volume":"180","author":"LC Hillman","year":"2004","unstructured":"Hillman LC, Chiragakis L, Shadbolt B, Kaye GL, Clarke AC (2004) Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett\u2019s oesophagus. Med J Aust 180:387\u2013391","journal-title":"Med J Aust"},{"key":"4103_CR26","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1007\/s10620-010-1209-2","volume":"55","author":"WD Chey","year":"2010","unstructured":"Chey WD, Mody RR, Izat E (2010) Patient and physician satisfaction with proton pump inhibitors (PPIs): are there opportunities for improvement? Dig Dis Sci 55:3415\u20133422","journal-title":"Dig Dis Sci"},{"key":"4103_CR27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2165\/00002512-200825020-00004","volume":"25","author":"N Weerasuriya","year":"2008","unstructured":"Weerasuriya N, Snape J (2008) Oesophageal candidiasis in elderly patients: risk factors, prevention and management. Drugs Aging 25:119\u2013130","journal-title":"Drugs Aging"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-015-4103-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00464-015-4103-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-015-4103-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T19:49:21Z","timestamp":1598730561000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00464-015-4103-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,13]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["4103"],"URL":"https:\/\/doi.org\/10.1007\/s00464-015-4103-3","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,13]]}}}